Topic Library
Clear answers to the questions patients actually ask
Short, evidence-based explainers on conditions, treatments, and the science worth knowing. Browse by category or search by keyword.
- Treatments
GLP-1 Medications and Hair Loss
If you've noticed more hair in the brush after starting semaglutide or tirzepatide, you're not imagining it — and you're not alone. A plain-language guide to why it happens, what the research actually shows, and what helps, plus a clinician section on evaluation and management.
GLP-1semaglutidetirzepatidehair-loss - Treatments
GLP-1 Medications and NAION
You may have seen headlines linking GLP-1 medications (semaglutide, tirzepatide) to a rare eye condition called NAION. A plain-language guide to what the research actually shows, who may be at higher risk, and the warning signs worth knowing — adapted from Dr. Maready's patient handout.
GLP-1semaglutidetirzepatideNAION - Treatments
Bariatric Surgery's Cardiometabolic Benefits
Five decades of evidence have established bariatric surgery as one of medicine's most powerful disease-modifying interventions — far beyond weight loss. A quick clinical reference to the mortality and cardiometabolic data anchored by SOS and the Lancet 174,772-patient meta-analysis.
bariatric-surgerymortalitycardiometabolicSOS - Condition
Cushing's Syndrome
Hypercortisolism — when too much cortisol, for too long, rewires almost every system in the body. Frequently missed, often misdiagnosed, and deeply underappreciated as a driver of difficult-to-control diabetes, hypertension, and weight gain.
cortisolhypercortisolismendocrineMACS - Lifestyle Medicine
The Many Benefits of Exercise
Why physicians who care about whole-person health keep returning to the same prescription. Mood, brain, beauty, metabolism, sleep, and the part of obesity care no medication can replace — synthesized from John Ratey's Spark, OMA 2026, and the 2024-2026 obesity-medicine literature.
exerciselifestyle medicinesparkratey - Case Study
Hidden Metabolic Dangers of Obesity
This 48-year-old man knew he was at risk — three first-degree relatives had had heart attacks and diabetes. He walked in at 210 pounds with a BMI of 31 — the lowest threshold the medical system calls obesity. What he didn't know was that his triglycerides were over 700, his blood pressure was already high, and his coronary arteries already showed calcium buildup (a marker of blockage). Three years later, the picture had been rewritten.
metaboliccase-study - Nutrition
Ultra-Processed Foods
Industrial formulations now make up the majority of calories in modern diets — and the evidence increasingly points to them as the leading driver of the obesity epidemic and a host of metabolic diseases.
- Lifestyle Environment
How Walkable Is Your City?
Three trips, three cities, three walks. A doctor's-eye field report on whether American cities are designed to move you — or move past you.
- Lifestyle Medicine
Walking
The most accessible, evidence-based intervention in medicine — and in 2022–2025 the data finally caught up to the common-sense advice. From mortality to mood to memory, the dose-response is real.
- Condition
Weight Loss, GLP-1 Therapy, & Gallstone Prevention
Rapid weight loss has always caused gallstones. GLP-1s add two more mechanisms on top of that — and the same prevention tool, at the same dose, works.
- Condition
Lipedema
A distinct, painful, progressive adipose disease — not obesity, not lymphedema. Recognizing it changes everything about how you treat the patient in front of you.
- Treatments
Menopause Hormone Therapy in Weight Management
MHT supports body composition and quality of life — but it's not a weight-loss drug. Where it fits, where it doesn't, and how to talk about it with midlife women.
- Treatments
Male Obesity-Associated Hypogonadism
Distinguishing true hypogonadism from low testosterone in men with obesity — and what to actually do about it.